Seeing Is Believing
Healthcare - Sector
EXEL is currently covered by 18 analysts with an average price target of $48.79. This is a potential upside of $4.29 (9.64%) from yesterday's end of day stock price of $44.5.
Exelixis's activity chart (see below) currently has 278 price targets and 232 ratings on display. The stock rating distribution of EXEL is 71.43% BUY and 28.57% HOLD.
Analysts average stock forecasts to be materialized ratio is 89.4% with an average time for these price targets to be met of 436.42 days.
Highest price target for EXEL is $56, Lowest price target is $30, average price target is $43.06.
Most recent stock forecast was given by SEAN LAAMAN from MORGAN STANLEY on 08-Jan-2026. First documented stock forecast 23-Nov-2015.
Currently out of the existing stock ratings of EXEL, 35 are a BUY (71.43%), 14 are a HOLD (28.57%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 29-Jul-2025
$48
$4.04 (9.19%)
$44
15 days ago
(08-Jan-2026)
2/4 (50%)
$1.81 (3.92%)
91
Buy
Since 26-Sep-2023
$52
$8.04 (18.29%)
$46
15 days ago
(08-Jan-2026)
9/12 (75%)
$5.81 (12.58%)
128
Hold
Since 17-Dec-2024
$41
$-2.96 (-6.73%)
$46
18 days ago
(05-Jan-2026)
6/7 (85.71%)
$-2.58 (-5.92%)
63
Hold
Since 19-Sep-2024
$40
$-3.96 (-9.01%)
$38
2 months 17 days ago
(06-Nov-2025)
3/4 (75%)
$-0.8 (-1.96%)
24
Buy
Since 17-Sep-2018
$42
2 months 20 days ago
(03-Nov-2025)
14/14 (100%)
$9.2 (28.05%)
439
What is EXEL (Exelixis) average time for price targets to be met?
Which analyst has the current highest performing score on EXEL (Exelixis) with a proven track record?
Which analyst has the most public recommendations on EXEL (Exelixis)?
Which analyst is the currently most bullish on EXEL (Exelixis)?
Which analyst is the currently most reserved on EXEL (Exelixis)?